Lonza walkersville, INC.:1110291 [21-003251]
Ended Awarded
- Contract number
- 75N95A21F00001
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,660
Award facts
- Contract value 100% obligated
- $13,660.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc. received a $13,660 firm fixed price contract from the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health, on December 18, 2020. This award was issued as a call against the company's existing $10 million blanket purchase agreement (BPA) with the HHS Office of Logistics and Acquisition Operations, valid through December 31, 2025. The contract was performed at the company's Walkersville, Maryland facility and represents typical task order activity under the broader BPA vehicle, which authorizes streamlined procurement of biological materials, cell culture media, laboratory supplies, and specialized scientific equipment supporting NIH research initiatives.
As a foreign-owned manufacturer specializing in high-precision biological research products, Lonza Walkersville has established itself as a critical federal supplier to the biomedical research community. This contract award involved no set-aside designation, indicating open competition within the existing BPA framework. The award aligns with the company's core business of providing advanced scientific instrumentation and biological materials—such as Nucleofector systems and cell processing devices—that support critical research across multiple NIH institutes in areas including neuroscience, infectious diseases, and regenerative medicine.
Quick answers
Who was awarded contract 75N95A21F00001?
75N95A21F00001 was awarded to Lonza Walkersville, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on December 18, 2020.
How much is contract 75N95A21F00001 worth?
The government has obligated $13,660 on 75N95A21F00001.
Is contract 75N95A21F00001 an order under another contract?
Yes. 75N95A21F00001 is a BPA call under HHSN263201600052B, a blanket purchase agreement.
Was contract 75N95A21F00001 competed?
The extent of competition for 75N95A21F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award